Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform.
Adaptor Proteins, Signal Transducing
/ genetics
Adult
Aged
Angiotensin-Converting Enzyme 2
/ genetics
Area Under Curve
Aromatic-L-Amino-Acid Decarboxylases
COVID-19
/ pathology
Dopa Decarboxylase
/ genetics
Down-Regulation
Epithelial Cells
/ cytology
Erythropoietin
/ genetics
Female
Humans
Male
Middle Aged
Nasopharynx
/ metabolism
Protein Isoforms
/ genetics
RNA-Binding Proteins
/ genetics
ROC Curve
SARS-CoV-2
/ genetics
Up-Regulation
Viral Load
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
01
12
2020
accepted:
06
06
2021
entrez:
29
6
2021
pubmed:
30
6
2021
medline:
13
7
2021
Statut:
epublish
Résumé
L-Dopa decarboxylase (DDC) is the most significantly co-expressed gene with ACE2, which encodes for the SARS-CoV-2 receptor angiotensin-converting enzyme 2 and the interferon-inducible truncated isoform dACE2. Our group previously showed the importance of DDC in viral infections. We hereby aimed to investigate DDC expression in COVID-19 patients and cultured SARS-CoV-2-infected cells, also in association with ACE2 and dACE2. We concurrently evaluated the expression of the viral infection- and interferon-stimulated gene ISG56 and the immune-modulatory, hypoxia-regulated gene EPO. Viral load and mRNA levels of DDC, ACE2, dACE2, ISG56 and EPO were quantified by RT-qPCR in nasopharyngeal swab samples from COVID-19 patients, showing no or mild symptoms, and from non-infected individuals. Samples from influenza-infected patients were analyzed in comparison. SARS-CoV-2-mediated effects in host gene expression were validated in cultured virus-permissive epithelial cells. We found substantially higher gene expression of DDC in COVID-19 patients (7.6-fold; p = 1.2e-13) but not in influenza-infected ones, compared to non-infected subjects. dACE2 was more elevated (2.9-fold; p = 1.02e-16) than ACE2 (1.7-fold; p = 0.0005) in SARS-CoV-2-infected individuals. ISG56 (2.5-fold; p = 3.01e-6) and EPO (2.6-fold; p = 2.1e-13) were also increased. Detected differences were not attributed to enrichment of specific cell populations in nasopharyngeal tissue. While SARS-CoV-2 virus load was positively associated with ACE2 expression (r≥0.8, p<0.001), it negatively correlated with DDC, dACE2 (r≤-0.7, p<0.001) and EPO (r≤-0.5, p<0.05). Moreover, a statistically significant correlation between DDC and dACE2 expression was observed in nasopharyngeal swab and whole blood samples of both COVID-19 and non-infected individuals (r≥0.7). In VeroE6 cells, SARS-CoV-2 negatively affected DDC, ACE2, dACE2 and EPO mRNA levels, and induced cell death, while ISG56 was enhanced at early hours post-infection. Thus, the regulation of DDC, dACE2 and EPO expression in the SARS-CoV-2-infected nasopharyngeal tissue is possibly related with an orchestrated antiviral response of the infected host as the virus suppresses these genes to favor its propagation.
Identifiants
pubmed: 34185793
doi: 10.1371/journal.pone.0253458
pii: PONE-D-20-37782
pmc: PMC8241096
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
EPO protein, human
0
IFIT1 protein, human
0
Protein Isoforms
0
RNA-Binding Proteins
0
Erythropoietin
11096-26-7
ACE2 protein, human
EC 3.4.17.23
Angiotensin-Converting Enzyme 2
EC 3.4.17.23
Dopa Decarboxylase
EC 4.1.1.-
Aromatic-L-Amino-Acid Decarboxylases
EC 4.1.1.28
DDC protein, human
EC 4.1.1.28
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0253458Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Eur Rev Med Pharmacol Sci. 2016 Dec;20(24):5067-5076
pubmed: 28051265
Apoptosis. 2021 Feb;26(1-2):7-8
pubmed: 33512610
J Virol. 2005 Dec;79(23):14614-21
pubmed: 16282461
J Med Virol. 2020 Oct;92(10):1743-1744
pubmed: 32246784
Clin Sci (Lond). 2014 Apr;126(7):507-16
pubmed: 24147777
PLoS Pathog. 2011 Oct;7(10):e1002289
pubmed: 22022264
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Signal Transduct Target Ther. 2020 Oct 9;5(1):235
pubmed: 33037188
Gene. 2019 Nov 30;719:144075
pubmed: 31449843
Int J Lab Hematol. 2021 Jul;43 Suppl 1:142-151
pubmed: 33554466
Cell Rep. 2021 Apr 20;35(3):109020
pubmed: 33852916
J Virol. 2000 Jun;74(11):4957-66
pubmed: 10799569
Cell Death Differ. 2004 Jul;11 Suppl 1:S37-44
pubmed: 15243580
Cells. 2018 Dec 01;7(12):
pubmed: 30513781
Front Cardiovasc Med. 2017 Jul 20;4:48
pubmed: 28775986
J Immunol Res. 2016;2016:3160486
pubmed: 27795960
PLoS One. 2010 Jun 17;5(6):e11159
pubmed: 20567522
Cell Host Microbe. 2021 Feb 10;29(2):267-280.e5
pubmed: 33357464
Emerg Microbes Infect. 2020 Dec;9(1):1418-1428
pubmed: 32529952
Virus Res. 2021 Apr 2;295:198283
pubmed: 33418027
Nat Rev Immunol. 2020 Jul;20(7):397-398
pubmed: 32457522
BMC Cancer. 2006 Jan 27;6:26
pubmed: 16438736
J Clin Invest. 1991 Sep;88(3):789-97
pubmed: 1653276
Microb Pathog. 2021 Sep;158:105114
pubmed: 34333072
J Gen Virol. 1979 Apr;43(1):247-52
pubmed: 113494
Microbes Infect. 2012 Mar;14(3):238-46
pubmed: 22094132
Biomolecules. 2020 Apr 12;10(4):
pubmed: 32290638
Biochimie. 2020 Oct;177:78-86
pubmed: 32835737
J Neurosci Nurs. 2000 Aug;32(4):234-8
pubmed: 10994538
Mol Med. 2020 Jun 16;26(1):58
pubmed: 32546125
Cells. 2019 Aug 05;8(8):
pubmed: 31387309
Biochimie. 2019 May;160:76-87
pubmed: 30796964
Zhonghua Er Bi Yan Hou Ke Za Zhi. 2002 Feb;37(1):34-7
pubmed: 12768792
Pharmaceuticals (Basel). 2021 Jan 12;14(1):
pubmed: 33445640
J Infect. 2020 Jun;80(6):607-613
pubmed: 32283152
Bioorg Med Chem. 2011 May 15;19(10):3120-7
pubmed: 21524588
J Cell Physiol. 2019 Nov;234(11):20420-20431
pubmed: 30989646
Nat Genet. 2020 Dec;52(12):1283-1293
pubmed: 33077916
J Inflamm (Lond). 2020 Oct 29;17:33
pubmed: 33139969
J Virol. 2015 Sep;89(17):8701-12
pubmed: 26109733
Am J Respir Cell Mol Biol. 2005 May;32(5):395-403
pubmed: 15695738
Biomed Res Int. 2017;2017:7404912
pubmed: 28127559
J Virol. 2013 Mar;87(5):2935-48
pubmed: 23269812
Front Cell Neurosci. 2018 Nov 26;12:461
pubmed: 30534058
Nat Biotechnol. 2020 Aug;38(8):970-979
pubmed: 32591762
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Emerg Microbes Infect. 2021 Dec;10(1):1065-1076
pubmed: 34013835
Nat Genet. 2021 Feb;53(2):205-214
pubmed: 33432184
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L631-40
pubmed: 19592460
J Biol Chem. 2004 Apr 9;279(15):14871-8
pubmed: 14744852
J Med Virol. 2020 Oct;92(10):1793-1794
pubmed: 32311107
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
J Neurol Sci. 1975 Sep;26(1):49-60
pubmed: 1159458
J Neurochem. 2009 Jul;110(2):622-30
pubmed: 19457096